iShares Biotechnology ETF
IBB
IBB
841 hedge funds and large institutions have $7.66B invested in iShares Biotechnology ETF in 2021 Q1 according to their latest regulatory filings, with 82 funds opening new positions, 292 increasing their positions, 269 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
841
Holders Change
-11
Holders Change %
-1.29%
% of All Funds
14.81%
Holding in Top 10
8
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-46.67%
% of All Funds
0.14%
New
82
Increased
292
Reduced
269
Closed
80
Calls
$329M
Puts
$825M
Net Calls
-$496M
Net Calls Change
+$188M
Top Buyers
| 1 |
1
BNP Paribas Financial Markets
Paris,
France
|
$235M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$311M |
| 3 |
3
Citigroup
New York
|
$329M |
| 4 |
4
CI Investments Inc
Toronto,
Ontario, Canada
|
$58.4M |
| 5 |
5
Millennium Management
New York
|
$38.3M |
